Agena Bioscience Appoints Peter Dansky as Chief Executive Officer

Life science industry executive to guide expansion of MassARRAY® platform into the clinical research and diagnostics markets SAN DIEGO – July 21, 2014 – Agena Bioscience, Inc., the provider of the MassARRAY® System for genetic analysis, announced today that Peter Dansky has joined the company as its Chief Executive... Read More

Agena Bioscience Introduces the Hemo ID Panel for Blood Group Genotyping at the 33rd International Congress of the ISBT in Seoul, Korea

Swiss Red Cross Study Recommends Replacing Kell, Kidd, Duffy Serotyping with Genotyping San Diego, Calif., June 4, 2014/PRNewswire/ — Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., today, introduced the Hemo ID™ Blood Group Genotyping Panel for the MassARRAY® System following a Swiss Red Cross... Read More

Agena Bioscience Aims to Advance the MassARRAY® System

Agena Bioscience aims to advance the MassARRAY System, a proprietary platform used in unlocking biological understanding from genetic studies. The vision is to leverage the unique capabilities of the MassARRAY system and make it an informative and cost-effective genetic analysis tool for use in clinical practice. The MassARRAY system... Read More
Showing: 21–26 of 26